Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Genta to appeal Genasense non-approvable letter in CLL

Feb. 8, 2007

European orphan drug designation for Fodosine in CTCL

Feb. 8, 2007

Elacyt to be studied for metastatic colorectal cancer

Feb. 8, 2007

Glufosfamide studied in new phase II trial for recurrent, sensitive SCLC

Feb. 8, 2007

Favorable data on the gemcitabine/Myocet combination from a phase II trial

Feb. 8, 2007

Clinical data on vinflunine in metastatic breast cancer presented

Feb. 8, 2007

WP-760 displays selectivity against melanoma cells in vitro

Feb. 8, 2007

Sequential schedule of docetaxel/gemcitabine shows promising activity in MBC

Feb. 7, 2007

Recent patents impart new therapeutic agents for cancer

Feb. 7, 2007

ZEN-012 active against a variety of tumors in vivo

Feb. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...